69
Growth Score
pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
332741
Abiologics develops Synteins™ using AI and chemistry for new biologics.
- Avak Kahvejian: Founding CEOPast Role: ProFound Therapeutics, Founding CEO
About the Company
Abiologics develops programmable therapeutics using a proprietary platform that combines generative artificial intelligence with high-throughput chemical protein synthesis. The company focuses on creating Synteins™, a new category of supranatural biologics engineered from non-natural building blocks such as D-amino acids. These molecules are
designed to address the structural and functional limitations of conventional biologics by enhancing protease resistance, reducing immunogenicity, and improving tissue accessibility.
